SCHEMBL9963534

SCHEMBL9963534

Cc1c2nc(NCCc3ccccn3)sc2cc2sc(NCC(=O)N3CCN(C4CCCC4)CC3)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.40
ACHE P22303 1/20 0.40
GRIN2B Q13224 1/20 0.40
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NOS3 P29474 2/20 0.37
NOS1 P29475 2/20 0.37
PTGS2 P35354 2/20 0.37
NOS2 P35228 1/20 0.37
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HTT P42858 1/20 0.37
OGA O60502 1/20 0.36
TP53 P04637 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963532 0.89 ALDH1A1 (0.46) BCHEACHEGRIN2BMAPTSMN1; SMN2
SCHEMBL9963580 0.86 ACHE (0.45) BCHEACHEGRIN2BPTGS2KDM4E
SCHEMBL9963511 0.86 ACHE (0.42) BCHEACHEGRIN2BSMN1; SMN2PTGS2
SCHEMBL9963585 0.84 BCHE (0.45) BCHEACHEGRIN2BMAPTPTGS2
SCHEMBL9963578 0.83 PTGS2 (0.44) MAPTSMN1; SMN2PTGS2KDM4EALDH1A1
SCHEMBL9963550 0.83 ACHE (0.42) BCHEACHEGRIN2BSMN1; SMN2PTGS2
SCHEMBL9963629 0.82 ACHE (0.42) BCHEACHEGRIN2BPTGS2KDM4E
SCHEMBL9963652 0.82 ACHE (0.46) BCHEACHEGRIN2BSMN1; SMN2PTGS2
SCHEMBL9963622 0.82 POLB (0.40) BCHEACHEGRIN2BPTGS2KDM4E
SCHEMBL9963623 0.81 ADORA2B (0.47) MAPTSMN1; SMN2PTGS2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 BCHE 3319/4885ACHE 1479/4885GRIN2B 4012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.